This report provides detailed analysis of worldwide markets for Paracetamol (CAS 103-90-2) from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Paracetamol (CAS 103-90-2) market and further lays out an analysis of the factors influencing the supply/demand for Paracetamol (CAS 103-90-2), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. There is poor evidence for fever relief in children. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours. Paracetamol is generally safe at recommended doses. Serious skin rashes may rarely occur. Too high a dose can result in liver failure. It appears to be safe during pregnancy and when breastfeeding. In those with liver disease, it may still be used, but lower doses should be taken.Paracetamol is classified as a mild analgesic. It does not have significant anti-inflammatory activity and how it works is not entirely clear. Paracetamol was discovered in 1877. It is the most commonly used medication for pain and fever in both the United States and Europe. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system. Paracetamol is available as a generic medication with trade names including Tylenol and Panadol among others. The wholesale price is less than 0.01 USD per dose. In the United States it costs about 0.04 USD per dose.
Browse Full Research Report With TOC: http://www.radiantinsights.com/research/global-paracetamol-cas-103-90-2-market-forecast-and-analysis-2016-2021
Report has been prepared based on the synthesis, analysis, and interpretation of information about the global Paracetamol (CAS 103-90-2) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Paracetamol (CAS 103-90-2) market are Mallinckrodt, Granules, Sri Krishna Pharmaceuticals, Anqiu Lu’an Pharmaceutical, Hebei Jiheng, Jiangsu Wuxi Rhodia, Zhejiang Kangle Pharmaceutical, Huagang Pharmaceutical.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Paracetamol (CAS 103-90-2) industry has been provided.
See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/pharmaceutical
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Toll Free: 1-888-202-9519